Back to Browse Journals » International Journal of Chronic Obstructive Pulmonary Disease » Volume 3 » Issue 4

Long-acting β2-agonists (LABA) in chronic obstructive pulmonary disease: efficacy and safety

Authors Andrea Rossi, Sonia Khirani, Mario Cazzola

Published 5 December 2008 Volume 2008:3(4) Pages 521—529

DOI http://dx.doi.org/10.2147/COPD.S1353

Andrea Rossi1, Sonia Khirani1, Mario Cazzola2

1Unit of Respiratory Diseases, Hospital of Bergamo, Bergamo, Italy; 2Unit of Respiratory Diseases, Department of Internal Medicine, University of Rome ‘Tor Vergata’, Rome, Italy

Abstract: COPD is characterized by progressive airflow obstruction which does not fully reverse to inhaled or oral pharmacotherapy. The management of patients with COPD has taken a totally new direction over the past 20 years, thank to the use of novel therapies aimed to improve and modify the natural history of COPD. Long-acting bronchodilators, including long-acting β2-agonists (LABAs), were introduced several years ago in order to enhance improvements in lung function, health status related quality of life, and reduce the rate of exacerbations. These effects can be boosted by the combination of LABAs with long-acting anticholinergic, and/or with inhaled corticosteroids. Inhaled LABAs are commonly well tolerated although adverse effects such as tremor and palpitations are occasionally troublesome.

Keywords: LABA, COPD, efficacy, safety

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF] 

 

Readers of this article also read:

Multifunctional materials for bone cancer treatment

Marques C, Ferreira JMF, Andronescu E, Ficai D, Sonmez M, Ficai A

International Journal of Nanomedicine 2014, 9:2713-2725

Published Date: 28 May 2014

Postpartum depression: psychoneuroimmunological underpinnings and treatment

Anderson G, Maes M

Neuropsychiatric Disease and Treatment 2013, 9:277-287

Published Date: 21 February 2013

A sandwich-type DNA electrochemical biosensor for hairpin-stem-loop structure based on multistep temperature-controlling method

Hong GL, Liu YH, Chen W, Weng SH, Liu QC, Liu AL, Zheng DX, Lin XH

International Journal of Nanomedicine 2012, 7:4953-4960

Published Date: 14 September 2012

Tat peptide-admixed elastic liposomal formulation of hirsutenone for the treatment of atopic dermatitis in Nc/Nga mice

Kang MJ, Eum JY, Jeong MS, Park SH, Moon KY, Kang MH, Kim MS, Choi SE, Lee MW, Lee DI, Bang H, Lee CS, Joo SS, Li K, Lee M-K, Seo SJ, Choi YW

International Journal of Nanomedicine 2011, 6:2459-2467

Published Date: 20 October 2011

Visualization of interaction between inorganic nanoparticles and bacteria or fungi

André Chwalibog, Ewa Sawosz, Anna Hotowy, et al

International Journal of Nanomedicine 2010, 5:1085-1094

Published Date: 6 December 2010

Management of depression in elderly stroke patients

Johan Lökk, Ahmad Delbari

Neuropsychiatric Disease and Treatment 2010, 6:539-549

Published Date: 26 August 2010

Binding fullerenol C60(OH)24 to dsDNA

Mariana Pinteala, Andrei Dascalu, Cezar Ungurenasu

International Journal of Nanomedicine 2009, 4:193-199

Published Date: 8 September 2009

Purple urine bag syndrome in nursing homes: Ten elderly case reports and a literature review

Chi-Hung Lin, Hsien-Te Huang, Chia-Chang Chien, Dong-Sheng Tzeng, For-Wey Lung

Clinical Interventions in Aging 2008, 3:729-734

Published Date: 5 December 2008